Prof. Rule’s data highlights from ICML 2017
Ibrutinib updates from ASH 2016
The 2016 International Workshop of the German CLL Study Group (GCLLSG)
BCR inhibitors improving CLL patient outcomes
Are combination therapies more efective for the treatment of relapsed refractory CLL?